Rheumacensus experts unite and call for essential psoriatic arthritis and axial spondyloarthritis care improvements – UCB
As part of its longstanding commitment to patients in rheumatology, UCB, a global biopharmaceutical company, is sponsoring an expert-led, multi-stakeholder programme called Rheumacensus. The programme aims to identify… read more.
